Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

MEDIROM Healthcare Technologies Inc. Unsponsored ADR (MRM) had Revenue of $54.77M for the most recently reported fiscal year, ending 2024-12-31.

Quarterly Annual

Figures for fiscal year ending 2024-12-31

Income Statement Financials
Revenue	$54.77M
Net Income	$0.98M
Cost of Goods Sold	$39.95M
Gross Profit	$14.83M
Operating Expenses	$54.89M
Operating Income	$-0.12M
Non-Operating Income/Expense	$0.43M
Pre-Tax Income	$0.31M
Normalized Pre-Tax Income	$0.05M
Income after Taxes	$0.91M
Income from Continuous Operations	$0.91M
Consolidated Net Income/Loss	$0.91M
Normalized Income after Taxes	$1.15M
EBIT	$-0.12M
EBITDA	$1.79M
Weighted-Average Shares Outstanding (Basic)	5.11M
Weighted-Average Shares Outstanding (Diluted)	5.85M
Earnings per Share (EPS) (Basic)	$0.19
Earnings per Share (EPS) (Diluted)	$0.19
Balance Sheet Financials
Current Assets	$17.86M
Property, Plant, and Equipment	$2.88M
Long-Term Assets	$35.54M
Total Assets	$53.40M
Current Liabilities	$27.60M
Long-Term Debt	$5.04M
Long-Term Liabilities	$19.28M
Total Liabilities	$46.88M
Common Equity	$6.52M
Tangible Shareholders Equity	$-3.57M
Shareholders Equity	$6.52M
Common Shares Outstanding	7.90M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-8.79M
Cash Flow from Investing Activities	$2.39M
Cash Flow from Financial Activities	$7.88M
Beginning Cash	$0.70M
End Cash	$2.17M
Increase/Decrease in Cash	$1.47M
Stock-Based Compensation	--
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	0.65
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.44
Debt to Equity Ratio	1.90
Gross Margin	27.07%
Operating Margin	-0.22%
EBIT Margin	-0.22%
EBITDA Margin	3.28%
Pre-Tax Profit Margin	0.57%
Profit Margin	1.79%
Free Cash Flow	$-9.26M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	1.03
Inventory Turnover	39.92
Receiveable Turnover	4.15
Days Sales in Receivables	88.04
Return on Equity	13.99%
Return on Tangible Equity	-25.57%
Return on Assets	1.71%
Return on Investments	7.89%
Book Value Per Share	$0.83
Free Cash Flow per Share	$-1.58
Operating Cash Flow per Share	$-1.50

Data from Zacks Investment Research, Inc.